You seem to be using an outdated version of Internet Explorer. Please note that this site does not support this browser version (a href="http://windows.microsoft.com/de-de/windows/end-support-help">as does Microsoft). You may experience design inconsistencies and error messages. We are sorry for any inconveniences.

News

Personal MedSystems GmbH gains international consortium and closes series B financing with a volume of EUR 5 million. Further EUR 0.7 million from existing investors expected.

23. January 2017
Personal MedSystems GmbH, founded in 2008 by Dr. Markus Riemenschneider and Felix Brand, adds Dutch investor KPN ventures, Sino German High-Tech Fund from Shenzhen/ Hong Kong and Düsseldorf’s NRW.Bank to its existing investor base, which includes French venture capital firm seventure, the KfW banking group and High-Tech Gründerfonds (HTGF). The capital will be used for sales growth and continued innovation More …

HepaRegeniX GmbH Raises €9 million in a Series A Financing to Develop Kinase Inhibitors for the Treatment of Acute and Chronic Liver Diseases

5. January 2017
HepaRegeniX GmbH, a new Biotech company developing innovative treatments for liver diseases, announced today the completion of a €9 million Series A financing. The round was led by Boehringer Ingelheim Venture Fund GmbH (BIVF) and Novo Seeds, and complemented by the High-Tech Gruenderfonds and coparion. HepaRegeniX develops a new and unique therapeutic concept for the treatment of liver diseases, discovered More …

Chinese Biotech Investor VIROAD takes over GILUPI

14. December 2016
The investors AURELIA, High-Tech Gründerfonds (HTGF), KfW, ILB, the venture capital fund of the Sparkassen of Brandenburg and Business Angels sell their GILUPI shares to the strategic partner VIROAD. GILUPI is a company developing and manufacturing personalized cancer diagnostics in Potsdam. Due to the takeover, GILUPI gets the opportunity to continue the development of its medical products and to diversify More …

High-Tech Gründerfonds, Think.Health Ventures and FLYINGHEALTH invest in M-sense, the certified medical app to combat migraines and headaches

23. November 2016
Tackling migraines with a smartphone: The M-sense app launched by Berlin-based start-up Newsenselab GmbH has only been available in the Google Play Store for three months, but it has already documented thousands of migraine and headache attacks and analysed what caused them. The app will soon also offer effective therapy options. Newsenselab GmbH is now the recipient of a six-figure More …

Mecuris GmbH secures seed financing for enabling digital prosthetics and orthotics

21. November 2016
High-Tech Gründerfonds (HTGF), together with Bayern Kapital, is investing in Munich-based medical technology startup Mecuris. Specialising in personalised and additively manufactured orthopaedic patient aids, Mecuris offers an innovative solution platform for hospitals and medical supply stores. The latest financing will be used to expand the platform and develop additional applications. Orthopaedic technology continues to be a largely manual, craft-based trade, More …

New routes in healthcare: BVMed, Earlybird, High-Tech Gründerfonds and BIOCOM AG publish “MedTech Radar 7”

14. November 2016
There is a growing need for innovation in the health system, but at the same time it is challenging to establish new healthcare solutions for the market. Many stakeholders such as insurance companies, investors and start-ups currently opt for alternative methods to achieve their goals. In its seventh issue, the media service “MedTech Radar”, a joint publication of the German More …

Rigontec Raises Additional €15M in Extended Series A to Advance Novel RIG-I Targeted Immuno-Oncology Therapeutics

6. September 2016
Rigontec, the leader in RIG-I targeting RNA therapeutics, today announced that it has secured EUR 15 million in a third and final closing of its Series A round. The financing represents additional capital from current investors Boehringer Ingelheim Venture Fund, Forbion Capital Partners, High-Tech Gründerfonds (HTGF), NRW.BANK, MP Healthcare Venture Management, Sunstone Capital and Wellington Partners Life Sciences. The funding More …

microDimensions receives Series A Financing for Digital Pathology Solutions

20. July 2016
microDimensions GmbH, a Munich-based software and service provider for digital pathology that specializes in automated image analysis raised a Series A financing round. The company’s unique image processing technology can significantly speed up and automate workflows in (pre-)clinical drug development studies and clinical diagnosis. A consortium of five investors, led by Business Angel Dr. Adriaan Hart de Ruijter and complemented More …

SeNostic GmbH raises seed round for the clinical development of a novel technology for the differential diagnosis of neurodegenerative diseases

25. January 2016
The diagnostics company SeNostic GmbH announced today the closing of a seed round of financing led by High-Tech Gründerfonds (HTGF). SeNostic will set out to develop and commercialize a reliable differential diagnostic test for neurodegenerative diseases including Alzheimer’s disease, Parkinson’s disease and dementia with Lewy-bodies. Currently, the company is validating its SeedCycler platform technology that makes use of highly specific, More …

Venture Capital: Evonik invests in SYNOSTE, a medical technology start-up in Düsseldorf and Helsinki

21. January 2016
High-tech implant will make leg-lengthening treatment easier and less painful New medical application with high performance polymer VESTAKEEP® PEEK from Evonik Technology estimated to be available on the market in 2017 Evonik Industries has invested in the start-up company SYNOSTE Oy via its venture capital arm and now holds a minority share in the medical technology company based in Düsseldorf More …